ICI	immune checkpoint inhibitor
CAR-T	chimeric antigen receptor-T
TNF-α	tumor necrosis factor α
NF-κB	nuclear factor κB
PD-1	programmed cell death 1
PD-L1	programmed cell death 1-ligand 1
CTLA-4	cytotoxic T-lymphocyte-associated antigen 4
OS	overall survival
PFS	progression-free survival
ORR	objective response rate
SBRT	stereotactic body radiation therapy
FDA	U.S. Food and Drug Administration
EMA	European Medicines Agency
TMB	tumor mutation burden
VEGF	vascular endothelial growth factor
VEGFR	vascular endothelial growth factor receptor
FGFR	fibroblast growth factor receptor
PDGFR	platelet-derived growth factor receptor
DC	dendritic cell
shRNA	short hairpin ribonucleic acid
miRNA	micro ribonucleic acid
MSC	mesenchymal stromal cells
TTFields	tumor-treating fields